Skip to main content
. 2009 Jul 8;284(36):24213–24222. doi: 10.1074/jbc.M109.000745

TABLE 1.

Summary of MALDI-TOF analysis of biotinylated XPA peptides

Presented are tryptic digest fragments containing biotinylated lysine residues. Lysine residues protected from modification in the presence of ATR are indicated by a +, whereas residues not protected by ATR are indicated by a −. The asterisk indicates that the biotinylated fragment is located in the His tag. The intensity of the biotinylated peptide peak 184–189 (Lys-188 + biotin) was at least 10-fold higher for free XPA treated with NHS-biotin than for XPA-ATR complex modified under identical conditions. Intensities of other biotinylated XPA peptide fragments in the absence and presence of ATR varied within ±20%.

Fragment Modified Lys Protection
(−18)–(−5)* −12*
31–32 31
87–110 89
136–141 137
152–158 157
164–168 167
184–189 188 +
190–207 204
218–221 218
216–221 217, 218
219–224 221, 222
222–227 222, 224
223–227 224
232–237 236
259–273 259
260–273 272